Q1 2026 EPS Estimates for Dr. Reddy's Laboratories Limited (NYSE:RDY) Decreased by Analyst

Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) – Stock analysts at Zacks Research lowered their Q1 2026 earnings per share estimates for Dr. Reddy’s Laboratories in a research note issued to investors on Wednesday, May 1st. Zacks Research analyst R. Department now expects that the company will earn $1.01 per share for the quarter, […]

Related Keywords

Reddy Laboratorie ,Reddy Laboratories Limited ,Reddy Laboratories ,Jefferies Financial Group ,Contravisory Investment Management Inc ,Aprio Wealth Management ,Zacks Research ,Hr Department ,Barclays ,Laboratories Limited ,Free Report ,Get Free Report ,Investment Management ,Wealth Management ,Trexquant Investment ,Global Generics ,Pharmaceutical Services ,Active Ingredients ,Laboratories Daily ,Dr Reddys Laboratories ,Nyse Rdy ,Ardy ,Medical ,Earnings Estimates ,